Literature DB >> 9721329

Inducible nitric oxide synthase in the liver: regulation and function.

B S Taylor1, L H Alarcon, T R Billiar.   

Abstract

The inducible nitric oxide synthase (iNOS) gene is expressed by hepatocytes in a number of physiologic and pathophysiologic conditions affecting the liver including septic and hemorrhagic shock. The molecular regulation of iNOS expression is complex and occurs at multiple levels in the gene expression pathway. The cytokines TNF-alpha, IL-1beta, and INF-gamma synergistically activate iNOS expression in the liver, and the human iNOS gene was first cloned from cytokine-stimulated hepatocytes. iNOS expression requires the transcription factor NF-kappaB and is down-regulated by steroids, TGF-beta, the heat shock response, p53, and nitric oxide (NO) itself. In vivo, hepatic iNOS induction is differentially regulated from the typical acute-phase reactants and is not expressed as a mandatory component of the acute phase response. Thus, numerous mechanisms have evolved to regulate iNOS expression during hepatocellular injury. Studies of the effects of NO in the liver demonstrate that induced NO synthesis plays an important role in hepatocyte function and protects the liver during sepsis and ischemia reperfusion. Its cytoprotective role is best exemplified in a rodent model of endotoxemia. Here the addition of the nonspecific NOS inhibitors significantly increased hepatic damage. NO exerts a protective effect through its ability to prevent intravascular thrombosis by inhibiting platelet adhesion and neutralizing toxic oxygen radicals. NO also exerts a protective effects both in vivo and in vitro by blocking TNF-alpha-induced apoptosis and hepatotoxicity, in part by a thiol-dependent inhibition of caspase-3-like protease activity. These studies demonstrate the cytoprotective effects of NO in the liver and suggest hepatic iNOS expression functions as an adaptive response to minimize inflammatory injury. In addition, NO has anti-tumor effects as well as known mutagenic effects, is involved in the systemic vasodilatation of cirrhosis, and has potent antimicrobial properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721329

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  40 in total

Review 1.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

2.  Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury.

Authors:  Guang-Jin Yuan; Xiao-Rong Zhou; Zuo-Jiong Gong; Pin Zhang; Xiao-Mei Sun; Shi-Hua Zheng
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  Expression and cellular localization of inducible nitric oxide synthase in lipopolysaccharide-treated rat kidneys.

Authors:  Jae-Youn Choi; Sun-Ah Nam; Dong-Chan Jin; Jin Kim; Jung-Ho Cha
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

Review 4.  Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.

Authors:  Cleva Villanueva; Cecilia Giulivi
Journal:  Free Radic Biol Med       Date:  2010-04-11       Impact factor: 7.376

5.  Effect of matrine on primary human hepatocytes in vitro.

Authors:  Xiaobing Gong; Yuan Gao; Guoqing Guo; Florian W R Vondran; Ruth Schwartlander; Ekaterina Efimova; Gesine Pless; Igor M Sauera; Peter Neuhaus
Journal:  Cytotechnology       Date:  2014-01-21       Impact factor: 2.058

6.  Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis.

Authors:  Elisabeth A Patton; Anne C La Flamme; Joao A Pedras-Vasoncelos; Edward J Pearce
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

8.  Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.

Authors:  A Stehr; F Ploner; I Tugtekin; M Matejovic; M Theisen; C Zülke; M Georgieff; P Radermacher; K-W Jauch
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

9.  PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes.

Authors:  Patricia A Loughran; Donna B Stolz; Stacey R Barrick; David S Wheeler; Peter A Friedman; Richard A Rachubinski; Simon C Watkins; Timothy R Billiar
Journal:  Nitric Oxide       Date:  2013-03-05       Impact factor: 4.427

10.  Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal.

Authors:  Dunyaporn Trachootham; Gang Chen; Wan Zhang; Weiqin Lu; Hui Zhang; Jinsong Liu; Peng Huang
Journal:  Free Radic Biol Med       Date:  2013-01-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.